DEDIFFERENTIATED LIPOSARCOMA

Clinical trials for DEDIFFERENTIATED LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new DEDIFFERENTIATED LIPOSARCOMA trials appear

Sign up with your email to follow new studies for DEDIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Terminated 1

Experimental pill tested to fight aggressive Fat-Cell cancer

Disease control Terminated

This study tested an oral capsule called TQB3616 against a placebo in adults with advanced dedifferentiated liposarcoma, a rare and aggressive cancer. The main goal was to see if the drug could delay cancer growth or extend life. The trial was stopped early after enrolling 26 of …

Matched conditions: DEDIFFERENTIATED LIPOSARCOMA

Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

DEDIFFERENTIATED LIPOSARCOMA

Get alerted when new DEDIFFERENTIATED LIPOSARCOMA trials appear

Experimental pill tested to fight aggressive Fat-Cell cancer